DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
Can DCTs Be Both Patient Centric And Financially Efficient For Sites?
While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.
-
Advancing Rare Disease Research With Patient Registries
In this Q&A, “Rare dad” Harsha Rajasimha, Ph.D. of IndoUSrare discusses the current state of rare disease research and explains how patient registries can help propel drug development for rare disease therapies.
DCT TECHNOLOGY RESOURCES
-
Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.
-
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Review this collection of case studies showcasing Medidata's capabilities in decentralized trials, including the industry's first fully decentralized megatrial, ADAPTABLE.
-
Obtain a complete understanding of enrollment, screening, consent, and data collection by diving into this introductory handbook on decentralized clinical trials.
-
Who wouldn’t rather wear a smartwatch than drive 75 miles to have someone measure their blood pressure? See how DCTs have the capacity to include more people from a broader range of demographics.
-
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.
-
Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.